Delivery Order SPE2DB22D3501-SPE2DB25FXG72

The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,581.07 to AmerisourceBergen Drug Corp for Vanflyta 17.7 mg tablets (28-count package) on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical supply vendor, particularly for military and veteran healthcare systems. The company's primary IDC vehicle with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support contract, enabling the supply of branded and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract serves various federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through a flexible procurement mechanism that supports the DLA's medical supply chain operations.